- Home
- SBGI vs MDXG Comparison
SBGI vs MDXG Comparison
Compare SBGI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- MDXG
- Stock Information
- Founded
- SBGI 1986
- MDXG 2006
- Country
- SBGI United States
- MDXG United States
- Employees
- SBGI N/A
- MDXG N/A
- Industry
- SBGI Broadcasting
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- SBGI Industrials
- MDXG Health Care
- Exchange
- SBGI Nasdaq
- MDXG Nasdaq
- Market Cap
- SBGI 970.9M
- MDXG 1.1B
- IPO Year
- SBGI 1995
- MDXG N/A
- Fundamental
- Price
- SBGI $13.95
- MDXG $6.94
- Analyst Decision
- SBGI Buy
- MDXG Buy
- Analyst Count
- SBGI 6
- MDXG 1
- Target Price
- SBGI $20.08
- MDXG $12.00
- AVG Volume (30 Days)
- SBGI 448.8K
- MDXG 430.1K
- Earning Date
- SBGI 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- SBGI 7.17%
- MDXG N/A
- EPS Growth
- SBGI N/A
- MDXG N/A
- EPS
- SBGI 0.74
- MDXG 0.21
- Revenue
- SBGI $3,481,000,000.00
- MDXG $363,774,000.00
- Revenue This Year
- SBGI N/A
- MDXG $12.68
- Revenue Next Year
- SBGI $9.52
- MDXG $8.18
- P/E Ratio
- SBGI $18.82
- MDXG $33.06
- Revenue Growth
- SBGI 8.11
- MDXG 6.85
- 52 Week Low
- SBGI $11.89
- MDXG $5.47
- 52 Week High
- SBGI $18.46
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- SBGI 48.83
- MDXG 46.16
- Support Level
- SBGI $13.19
- MDXG $6.81
- Resistance Level
- SBGI $14.37
- MDXG $7.14
- Average True Range (ATR)
- SBGI 0.39
- MDXG 0.19
- MACD
- SBGI -0.03
- MDXG -0.04
- Stochastic Oscillator
- SBGI 50.67
- MDXG 26.53
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.